Category:

NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients – Yahoo Finance

CONTEXT:  On the back of previous news stories about genetic biomarker testing in NSCLC, Neogenomics announces the launch of KRAS G12C testing to eligible advanced / late stage NSCLC cancer Continue Reading

Posted On : Published By : Ken Ashman
Category:

New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection and Reduction of Migraine Burden Presented at 2021 American Academy of Neurology Virtual Annual Meeting – Business Wire

CONTEXT:  It seems that having Real-World Data (capitalised for emphasis) alongside your traditional clinical data at a poster presentation now adds weight to the overall message.  RWR is the must-have Continue Reading

Posted On : Published By : Ken Ashman
Category:

Gynesonics Announces Publication of SAGE Global Registry Preliminary Results: Real-World Usage Corroborates the Safety and Applicability of Sonata Transcervical Fibroid Ablation – Yahoo Finance

CONTEXT:  Publication of RWE derived from the SAGE global registry reinforces the safety of Transcervical ablation of fibroids. IMPACT:  Low READ TIME:  2 mins Quality Level Mean [1 – 10]: Continue Reading

Posted On : Published By : Ken Ashman
Category:

Tolmar Publishes Study in the February Issue of Journal of Urology on the Impact of Late Dosing on Testosterone Suppression with Two Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere – An Analysis of US Clinical Data – PRNewswire

CONTEXT:  Commercially sponsored announcement of a retrospective study published in Journal of Urology looking at the impact of late luteinizing hormone-releasing hormone agonist dosing on testosterone suppression in patients with prostate Continue Reading

Posted On : Published By : Ken Ashman